Immediate Impact
16 standout
Citing Papers
Advances in conducting nanocomposite hydrogels for wearable biomonitoring
2025 Standout
Antibody–Drug Conjugates (ADCs): current and future biopharmaceuticals
2025 Standout
Works of Dory Freeman being referenced
Comprehensive metabolomic profiling of plasma from patients (pts) with metastatic urothelial carcinoma (mUC) receiving immune checkpoint inhibitors (ICI) or platinum-based chemotherapy (PBC).
2022
Impact of FGFR2/3 activating genomic alterations on response to enfortumab vedotin in metastatic urothelial carcinoma (mUC).
2021
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Dory Freeman | 38 | 36 | 35 | 25 | 88 | |
| Paul S. Lavik | 37 | 45 | 17 | 15 | 168 | |
| Gabriele Infante | 46 | 59 | 76 | 26 | 177 | |
| Ioanna Nixon | 19 | 55 | 44 | 21 | 173 | |
| P. Spadaro | 22 | 73 | 58 | 22 | 155 | |
| Danny Jazmati | 17 | 33 | 18 | 22 | 102 | |
| Kim C. Wagner | 81 | 32 | 40 | 24 | 185 | |
| Andrew H. Dowdy | 32 | 58 | 42 | 22 | 188 | |
| Shohei Mori | 24 | 80 | 40 | 21 | 173 | |
| Satish Shah | 24 | 64 | 28 | 19 | 163 | |
| M. Murcia | 12 | 53 | 46 | 17 | 174 |
All Works
Login with ORCID to disown or claim papers
Loading papers...